.png)
Meet us at booth #115
Gentian Diagnostics is pleased to announce our participation at IFCC EuroMedLab Congress - EuroMedLab 2025 - in Brussels, one of the most important global events for clinical chemistry and laboratory medicine. We invite you to visit us at Booth #115, where our team will be on-site, sharing insights about our IVDR certified assays, used in laboratories around the world.
Assays designed for open channels
Gentian Diagnostics is a Norwegian IVD company at the forefront of developing and manufacturing Particle-Enhanced Turbidimetric Immunoassays (PETIA) for open-channel use on most clinical chemistry platforms.
Gentian is committed to developing robust diagnostic assays for seamless implementation, that help laboratories deliver fast and accurate results. Our assays are widely adopted in labs globally.
Expanding portfolio across clinical areas
Our expanding portfolio of assays addresses key areas such as kidney disease, inflammation, infection, heart failure (in development), and veterinary diagnostics.
Our product range includes:
- Cystatin C
- GCAL® plasma and serum calprotectin
- Canine CRP
- RPB – Retinol-Binding Protein
- NT-proBNP - in development
Explore our full portfolio: www.gentian.com/products
Global vision from our HQ in Norway
From R&D and production to marketing and distribution, all Gentian operations are managed from our headquarters in Norway. Through close partnerships with clinical laboratories and instrument providers around the world, we are delivering assays that help improve efficiency and accuracy, and ultimately better patient outcomes.
Meet the Gentian team at EuroMedLab 2025
Our team of scientists, product specialists, and commercial experts will be on-site at booth #115. We are looking forward to engaging with laboratory professionals, partners, and industry peers to discuss how Gentian’s assays can support better diagnostics. We look forward to meeting you!
Want to schedule a meeting? Get in touch in advance to book a time.
Get in touch
.jpg)
.jpg)
.png)